Latest Breaking News On - Vector product engineering - Page 1 : vimarsana.com

Replicate Bioscience Announces Oral Presentations at the 2024 American Society of Gene & Cell Therapy (ASGCT) Annual Meeting

Replicate Bioscience, a clinical-stage company pioneering novel self-replicating RNA (srRNA) technology for use in infectious disease, oncology, autoimmune disease, and more, today announced acceptance of two oral presentations at the upcoming.

United statesZelanna goldbergAmerican society of gene cell therapyBioscience announces oral presentationsCell therapyReplicate bioscienceAmerican societyAnnual meetingNovel self replicatingBroaden therapeutic windowExpand use outsideEmerging viralLow dose self replicatingVector product engineeringApple tree partners

Interius BioTherapeutics to Present In Vivo CAR Data in Oncology and Autoimmunity Programs at the American Society of Gene and Cell Therapy 27th Annual Meeting

/PRNewswire/ Interius BioTherapeutics, a leading developer of in vivo cell-specific gene medicines, today announced the presentation of preclinical data.

United statesPrnewswire interius biotherapeuticsPhil johnsonDetargeted vesiculovirus fusogenAmerican society of geneAnalytics assay developmentAmerican societyCell therapyAnnual meetingVivo generationEnable targeted in vivo geneEmerging viralVector sheddingSingle intravenous infusionTargeted engineered lentiviralPharmacology toxicology studies

Replicate Bioscience Announces Oral Presentations At The 2024 American Society Of Gene & Cell Therapy (ASGCT) Annual Meeting

Replicate Bioscience Announces Oral Presentations At The 2024 American Society Of Gene & Cell Therapy (ASGCT) Annual Meeting
menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.

United statesZelanna goldbergAmerican society of gene cell therapyAmerican societyCell therapyAnnual meetingNovel self replicatingBroaden therapeutic windowExpand use outsideEmerging viralLow dose self replicatingVector product engineering

Vedere Bio II Presents Positive New Data Supporting Its Proprietary Platform at the 25th Annual ASGCT Meeting

/PRNewswire/ Vedere Bio II, Inc., a company developing transformative, next-generation therapies for vision restoration and preservation, today will present.

United kingdomUnited statesGabor veresPrnewswire vedere bio ii incDevelopment or manufacturingMeeting of the american society geneOral presentation identifies three novelHigh retinal transductionData supports utilityNovel cell lineAnnual meetingAmerican societyCell therapyChief scientific officerVedere bioIntravitreal delivery

Capsida Biotherapeutics Presents Data Demonstrating Unique Industry-Leading Technology and Capabilities With Potential to Treat Both Rare and Common Diseases at the Annual Meeting of the American

Platform utilizes combinatorial engineering and automation to screen in high-throughput, generating capsids greatly improved over AAV9 in CNS effi.

United statesXiaojing shiHari acharyaNick goedenTroy sandbergLaura adamsonPrnewswire capsida biotherapeuticsCapsida biotherapeuticsViviana gradinaruCalifornia institute of technologyAmerican society of gene cell therapyWaltere washington convention centerAmerican societyCell therapyEngineering across multiple surface exposed loopsCapsids with high degrees